{
    "10.1039_c8sc04808h.pdf": {
        "new materials": {
            "Yes/No": "No",
            "sentence": " The unexpected presence of Ni(II)-thienyl iodide a\ue09der poly-\nmerizing XMg-Th-Cl or XMg-Th-Br (I"
        },
        "screening algorithms": {
            "Yes/No": "No",
            "sentence": " The KCTP catalytic cycle involves four steps: transmetalation (TM), reductive elimination (RE), ring walking (RW) and oxidative addition (OA) (Scheme 1)."
        },
        "experimental methodology": {
            "Yes/No": "Yes",
            "sentence": " The current study utilized DFT calculations to determine activation energies for TM propagating polymer chain, likely due to the difficult OA or other side reactions."
        },
        "ML algorithms": {
            "Yes/No": "No",
            "sentence": " The document does not mention the development of any new machine learning and deep learning algorithm or AI model"
        },
        "models": {
            "Yes/No": "Yes",
            "sentence": " We developed a novel synthesis method for hydrothermal reactions under a phosphoric acid medium and obtained a series of metal polyiodates with strong SHG effects."
        },
        "funding": {
            "Yes/No": "Yes",
            "sentence": " I thank the editor for providing me with an advance copy of the article for refereeing."
        },
        "material datasets": {
            "Yes/No": "No",
            "sentence": " The unexpected presence of Ni(II)-thienyl iodide after polymerizing XMg-Th-Cl or XMg-Th-Br (I"
        },
        "drug formulations explored": {
            "Yes/No": "Yes",
            "sentence": " Notably, they can be incorporated in pharmaceutical formulations to enhance drug solubility, absorption, and bioavailability due to the formulation itself and the P-gp inhibitory effects of the excipients."
        },
        "novel drug formulations": {
            "Yes/No": "Yes",
            "sentence": " The observed singlet does not match any intermediates in the catalytic cycle (complex 1\u20134 in Scheme 1), suggesting that some of the active catalyst is diffusing away from the propagating polymer chain, likely due to other side reactions."
        },
        "lead small-molecule drug candidates": {
            "Yes/No": "Yes",
            "sentence": " The general, cross coupling occurs between two complementary functional groups: an organometallic group (Mg, Zn, Sn or B) and an organic halide (Cl, Br, I)."
        },
        "clinical trials": {
            "Yes/No": "No",
            "sentence": " There are no specific sentences about clinical trials mentioned in the document. However, some phrases like \"polymerization of XMg-Th-Cl\", \"XMg-Th-I\" and others can be interpreted as experimental procedures or conditions, but they do not clearly indicate any kind of clinical trial."
        }
    }
}